Genlabs Healthcare Private Limited
Founded: 2013
Status: Active
Designation: Director
Suresh Maloor Srinivasan - Profile
Suresh Maloor Srinivasan, Director and Designated Partner, with 5 companies.
About
Suresh Maloor Srinivasan
Suresh Maloor Srinivasan has 10 years in corporate governance. Holds Director and Designated Partner roles. Currently with 4 companies, including Genlabs Healthcare Private Limited and Phiduciam Consulting Llp. Formerly with 1 company, such as Genlabs Healthcare Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current Companies
4
Past Companies
1
Total Affiliations
5
Oldest Company Age
12
Companies Associated with Suresh Maloor Srinivasan
Current Companies
Phiduciam Consulting Llp
Founded: 2016
Status: Strike Off
Designation: Designated Partner
Vriddhi Worldpro Private Limited
Founded: 2025
Status: Active
Designation: Director
Veristep India Private Limited
Founded: 2022
Status: Active
Designation: Additional Director
Previous Companies
Genlabs Healthcare Private Limited
Founded: 2013
Status: Active
Designation: Additional Director
Explore Director's current and past company associations— Uncover their professional journey today!
Frequently Asked Questions
Who is Suresh Maloor Srinivasan?
Suresh Maloor Srinivasan has 10 years in corporate governance. Holds Director and Designated Partner roles. Currently with 4 companies, including Genlabs Healthcare Private Limited and Phiduciam Consulting Llp. Formerly with 1 company, such as Genlabs Healthcare Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
What is Suresh Maloor Srinivasan's role in current companies?
Suresh Maloor Srinivasan is associated with 4 companies as Director and Designated Partner.
What industries does Suresh Maloor Srinivasan specialize in?
Suresh Maloor Srinivasan has expertise in Healthcare, General Business.
How many years of experience does Suresh Maloor Srinivasan have?
Suresh Maloor Srinivasan has 10 years in corporate governance.